This information is intended for UK and Irish patients prescribed abatacept only.
The information on this website is only intended for UK patients who have been prescribed abatacept.
Select an administration device below
Pre-Filled Syringe
The ORENCIA® (abatacept) Pre-Filled Syringe Patient Administration Video is developed for patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) or polyarticular juvenile idiopathic arthritis (pJIA) who have been prescribed, are preparing for or currently receiving treatment with ORENCIA® (abatacept).
This website and the information found within it is not intended to replace in any way the opinion of a healthcare professional. For specific information about disease pathology, detection, diagnosis, prognosis, administration and, where applicable, the appropriate treatment for each specific case, please promptly consult a healthcare professional.
If you are a patient based in Great Britain, further information can be found in the
If you are a patient based in Ireland or Northern Ireland, further information can be found in the
You can also download the following abatacept support materials from the links below:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly.
UK - see www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store for how to report side effects.
Ireland - via HPRA Pharmacovigilance at www.hpra.ie.
Side effects should also be reported to Bristol Myers Squibb via medical.information@bms.com or 0800 731 1736 (UK); 1 800 749 749 (Ireland).
By reporting side effects you can help provide more information on the safety of this medicine.